Achyut Healthcare Limited

BSE: ACHYUT · Pharmaceuticals · sector

₹7.30BSE close 2026-10-26

Key numbers

Market cap₹176 cr

Price₹7.30

52w high / low₹10 / ₹5

P/E243.3xSector median 27.9x

P/B5.0xSector median 2.9x

Book value₹1.4

Dividend yield–Sector median 0.48%

ROE2.0%Sector median 11.7%

ROCE1.8%Sector median 12.3%

OPM2.4%Sector median 14.0%

Debt / equity0.00xSector median 0.16x

EV/EBITDA494.0xSector median 18.6x

Interest cover13.2x

Current ratio4.59x

Sales growth 3y+62.5%Sector median +9.6%

Profit growth 3y+11.2%Sector median +13.3%

PEG–

Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹3 cr vs borrowings ₹0 cr (FY26): cash is higher (net cash).
Operating profit covered interest 13.2x in the last 12 months.
Other income was 98% of net profit in the last 12 months.
No dividend in the last 5 financial years.
Price ₹7.30 on 2026-10-26: -27.3% from the 52-week high, +55.3% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹9.13 · low ₹3.20

Quarterly results

₹ cr	Mar 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	1	6	2	4	3
EBITDA	-0	0	0	0	0
OPM %	-14.1%	2.7%	0.0%	0.7%	5.8%
Other income	0	0	0	0	0
Net profit	0	0	0	0	0
EPS (₹)	0.01	0.01	0.00	0.01	0.01
Revenue YoY					+240.2%
Profit YoY					-30.0%

Standalone figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	4	3	6	3	12	15
EBITDA	-0	-0	0	-0	0	0
Net profit	0	0	1	1	0	0
EPS (₹)	0.15	0.03	0.34	0.02	0.01	0.03
Revenue growth		-33.3%	+127.4%	-50.3%	+280.0%	–
Profit growth		+475.0%	+147.8%	-3.5%	-41.8%	–
Dividend / share (₹)	–	–	–	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	+62.5%	–	–
Net profit	+11.1%	–	–
EPS	-30.7%	–	–
Share price	–	-69.6% (2y)	+11.8%

Balance sheet

₹ cr	FY25	FY26
Shareholders' equity	8	35
Borrowings	–	0
Cash & equivalents	1	3
Total assets	33	38
Fixed assets	0	0
Capital work in progress	–	28
Investments	0	0
Receivables	–	1
Inventory	0	0
Payables	–	1

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY25	FY26
Cash from operations	-4	1
Cash from investing	5	-2
Cash from financing	0	3
Capex	11	8
Free cash flow	-15	-7

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY25	FY26
ROE %	7.1%	0.9%
ROCE %	9.1%	1.2%
Debtor days	–	46
Inventory days	24	16
Payable days	–	44
Cash conversion cycle (days)	–	18
Working capital days	1,289	194

Peers in Pharmaceuticals

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
SUNPHARMA	₹4,17,478 cr	34.5x	5.0x	15.5%	18.7%	28.6%	+10.0%	0.94%
DIVISLAB	₹2,39,825 cr	82.1x	14.3x	18.4%	23.0%	34.7%	+10.8%	0.34%
TORNTPHARM	₹1,53,999 cr	72.7x	18.4x	27.3%	15.1%	32.3%	+13.3%	0.84%
ZYDUSLIFE	₹1,15,808 cr	25.9x	4.3x	17.7%	16.8%	27.2%	+16.4%	0.95%
LAURUSLABS	₹1,11,232 cr	101.6x	21.0x	22.4%	20.8%	28.0%	+4.1%	0.08%
CIPLA	₹1,09,464 cr	32.5x	3.2x	10.3%	13.2%	17.7%	+7.4%	1.18%
DRREDDY	₹1,09,460 cr	33.9x	2.9x	9.0%	10.1%	15.5%	+11.0%	0.61%
MANKIND	₹95,486 cr	46.7x	5.9x	13.4%	13.8%	25.1%	+17.7%	0.04%
AUROPHARMA	₹91,489 cr	24.9x	2.4x	10.5%	12.8%	20.0%	+10.6%	0.26%
ACHYUT	₹176 cr	243.3x	5.0x	2.0%	1.8%	2.4%	+62.5%	–

All 185 companies in Pharmaceuticals →

Documents

Links go to the original files on the exchange website.

About the company


Sector	Healthcare
Industry	Pharmaceuticals
Sub-industry	Pharmaceuticals
Symbol	ACHYUT
BSE code	543499
ISIN	INE0K1401020
Face value	₹1.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.